Genital Mycotic Infections in Patients With Diabetes

@article{Nyirjesy2013GenitalMI,
  title={Genital Mycotic Infections in Patients With Diabetes},
  author={P. Nyirjesy and J. Sobel},
  journal={Postgraduate Medicine},
  year={2013},
  volume={125},
  pages={33 - 46}
}
Abstract Patients with diabetes, especially those with poorly controlled glycemia, are prone to developing genital mycotic infections—vulvovaginal candidiasis in women and Candida balanitis in men—the latter almost exclusively in uncircumcised men. Candida albicans is the most common pathogen causing balanitis and is also the dominant cause of vulvovaginal candidiasis in women with diabetes, although Candida glabrata is a prominent pathogen in women with type 2 diabetes mellitus. Candida… Expand
Vulvovaginal Candidiasis: Epidemiology and Risk Factors, Pathogenesis, Resistance, and New Therapeutic Options
Purpose of Review Vulvovaginal candidiasis (VVC) is an infection of the vaginal mucosa caused by fungi of the genus Candida and can become pathogenic under special conditions. It affects about 75% ofExpand
Candida sp. Infections in Patients with Diabetes Mellitus
TLDR
Results of the review show that DM patients have an increased susceptibility to Candida sp. Expand
A Murine Model of Candida glabrata Vaginitis Shows No Evidence of an Inflammatory Immunopathogenic Response
TLDR
Data suggests that experimental vaginal colonization of C. glabrata is not associated with an inflammatory immunopathogenic response or biofilm formation, and suggests that host responses to infection following efforts to optimize a murine model of the organism are not affected. Expand
Highlights Regarding Host Predisposing Factors to Recurrent Vulvovaginal Candidiasis: Chronic Stress and Reduced Antioxidant Capacity
TLDR
The data suggest that both chronic stress (decreased early-morning cortisol levels) and reduced antioxidant capacity can be host predisposing factors to RVVC. Expand
Candidosis vaginal. primera parte: revisión de la clínica, epidemiología y situación de México
TLDR
This section presents data from different authors in terms of etiology, epidemiology, physiopathogeny and the clinical profile of vulvovaginal candidosis, with special attention to the current scenario in Mexico, a country where it is the only mycosis of mandatory reporting to health authorities. Expand
[The role of the symptomatic and asymptomatic sexual partners in the recurrent vulvovaginitis].
TLDR
There was a predominance of C. albicans in male partners with the recurrence of vaginitis and symptomatic or asymptomatic partners can play an important role as a reservoir and source of transmission of yeast, especially in cases of recurrent vulvovaginitis. Expand
The Epidemiology of Candida Species Isolated From Urinary Tract Infections
TLDR
C. albicans was the most common species isolated from patients with vulvovaginitis and UTI, and significantly more common amongst females compared to males, and the prevalence of candida spp. Expand
Genetic diversity and molecular epidemiology of Candida albicans from vulvovaginal candidiasis patients.
TLDR
The analysis of the genotypes of multiple isolates from RVVC patients further demonstrated that point mutation and loss of heterozygosity contributed to the microevolution of C. albicans. Expand
High Prevalence of Genital Mycotic Infections with Sodium-glucose Co-transporter 2 Inhibitors among Indian Patients with Type 2 Diabetes
TLDR
There is a very high risk of genital mycotic among Indian patients with T2D on SGLT2i and precautions needed to minimise the risk. Expand
Diabetes and Infection
TLDR
The risk and frequency of infections is higher in persons with type 1 and type 2 diabetes and the risk of life-threatening infections can be minimized with diabetes self-care and support education, along with optimal glycemic control. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 142 REFERENCES
Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.
TLDR
Overall only one third of patients with diabetes mellitus and VVC respond to single dose 150 mg of fluconazole therapy, which is explained by the high prevalence of C. glabrata infection. Expand
Pathogenesis of Candida vulvovaginitis.
  • J. Sobel
  • Biology, Medicine
  • Current topics in medical mycology
  • 1989
TLDR
The pathogenesis of CVV is discussed in terms of the microbiology, adherence, germ tube and mycelium formation, proteinase secretion, and switching colonies, and the development of virulent symptoms, which is capsuled in the following comments. Expand
Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status.
TLDR
There seems to be a significant link between hyperglycaemia and vulvo-vaginal candidiasis in diabetics with diabetes mellitus and healthy controls. Expand
Chronic vulvovaginal candidiasis: characteristics of women with Candida albicans, C glabrata and no candida.
TLDR
It is suggested that reliance on symptoms and signs alone will result in significant misdiagnosis of chronic vulvovaginitis and vaginal yeast cultures, while not necessary for every patient, are valuable in confirming negative diagnoses, detecting microscopy false-negatives, and identifying non-C albicans isolates. Expand
Prevalence of vaginal candidiasis infection in diabetic women
TLDR
Vulvovaginal candidiasis was more prevalent in women without blood glucose level control than ones with blood glucoselevel control and C. albicans was, by far, the most predominant yeast isolate. Expand
Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis.
  • J. Sobel
  • Medicine
  • American journal of obstetrics and gynecology
  • 1985
TLDR
Evidence is presented of an increasing incidence of vulvovaginal candidiasis, the cause of which is unclear, but this increase is probably the result of multiple factors including widespread abuse of antibiotics, possibly oral contraceptives, and most important inadequate vaginal therapy. Expand
Vulvovaginal Candidiasis in Children and Adolescents with Type I Diabetes Mellitus
TLDR
The frequency of vulvovaginal candidiasis, the results of yeast cultures and detection of ketoconazole resistance in female children and adolescents with type 1 diabetes mellitus (DM1) is investigated and Candida species isolated from patients with DM1 were identified. Expand
Candida glabrata: Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison toC. albicans
TLDR
This review summarizes all known clinical and experimental information about C. glabrata infections with comparisons to C. albicans as a means of contrasting the two species commonly observed and emphasizing the many recognized differences. Expand
Genetic Basis for Recurrent Vulvo-Vaginal Candidiasis
TLDR
This review summarizes the immunogenetic alterations that lead to an increased susceptibility to vaginal infections with Candida albicans and identifies different mutations and polymorphisms in innate immune genes that alter the mucosal immune response against fungi. Expand
Recurrent genital candidosis in women and the effect of intermittent prophylactic treatment
TLDR
The results of the study suggested that symptoms in women with recurrent genital candidosis were not caused byYeasts alone, and possibly the reason for recurrences might lie not in constant reinfection by yeasts, but in failure to recognise and remove a primary underlying factor, perhaps infection with other sexually transmitted agents. Expand
...
1
2
3
4
5
...